Venture Visionary Partners LLC Sells 1,601 Shares of Colgate-Palmolive (NYSE:CL)

Venture Visionary Partners LLC reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 12.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,364 shares of the company’s stock after selling 1,601 shares during the quarter. Venture Visionary Partners LLC’s holdings in Colgate-Palmolive were worth $1,180,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in CL. Main Street Research LLC increased its position in shares of Colgate-Palmolive by 1.5% during the second quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock worth $673,000 after purchasing an additional 100 shares in the last quarter. Advisor OS LLC grew its stake in shares of Colgate-Palmolive by 4.5% during the second quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock worth $228,000 after acquiring an additional 101 shares during the last quarter. BLB&B Advisors LLC increased its holdings in shares of Colgate-Palmolive by 2.5% during the second quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock valued at $421,000 after acquiring an additional 104 shares in the last quarter. ZWJ Investment Counsel Inc. raised its position in shares of Colgate-Palmolive by 3.1% in the 2nd quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock valued at $349,000 after purchasing an additional 109 shares during the last quarter. Finally, Hexagon Capital Partners LLC boosted its stake in Colgate-Palmolive by 9.5% in the 2nd quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock worth $124,000 after purchasing an additional 110 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Transactions at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. In other news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock valued at $4,486,063 over the last 90 days. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Stock Up 0.3 %

Shares of NYSE CL opened at $99.68 on Wednesday. Colgate-Palmolive has a 52-week low of $71.46 and a 52-week high of $109.30. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. The company’s 50-day simple moving average is $103.38 and its 200-day simple moving average is $97.83. The firm has a market cap of $81.78 billion, a price-to-earnings ratio of 31.54, a price-to-earnings-growth ratio of 3.54 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. The company had revenue of $5.06 billion during the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. Colgate-Palmolive’s quarterly revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.77 EPS. Equities analysts predict that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.01%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Jefferies Financial Group cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price target for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. TD Cowen increased their price objective on Colgate-Palmolive from $110.00 to $115.00 and gave the company a “buy” rating in a report on Tuesday, July 30th. Wells Fargo & Company downgraded Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 target price for the company. in a report on Monday, September 16th. Stifel Nicolaus increased their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Monday, July 22nd. Finally, Evercore ISI lifted their price objective on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $106.00.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.